Diagnosis category
Adrenocortical carcinoma, metastasis, pheochromocytoma differential or uncertain adrenal mass is clarified.
A rare-tumor review for adrenal masses and adrenal cancer, focused on diagnosis clarity, hormonal activity, imaging features, surgical history, metastatic pattern and endocrine safety before any international coordination.
Adrenal cancer evaluation requires caution because an adrenal mass can represent adrenocortical carcinoma, metastasis from another cancer, pheochromocytoma or a benign lesion. Hormonal activity can create medical risks that must be recognized before planning.
The file should be reviewed with endocrine-oncology discipline: imaging characteristics, hormone tests, biopsy/surgery history and current symptoms must be organized before any treatment route is discussed.
Adrenocortical carcinoma, metastasis, pheochromocytoma differential or uncertain adrenal mass is clarified.
Cortisol, aldosterone, androgens, catecholamines/metanephrines and clinical symptoms are reviewed when available.
Size, growth rate, HU/washout, invasion, vascular involvement and metastatic sites are documented.
Adrenalectomy, margins, capsule rupture, lymph nodes and postoperative course are summarized.
Mitotane, chemotherapy, immunotherapy or other treatments are listed with response and toxicity.
Blood pressure, potassium, cortisol excess, infection risk and performance status are included.
Each item below affects how the file is interpreted, what the physician can answer and whether additional documents are needed before a responsible response.
Functioning tumors can cause blood pressure, potassium, cortisol or catecholamine risks that affect safety.
The review avoids assuming every adrenal mass is adrenal cancer.
Margins, rupture and recurrence timing can affect specialist interpretation.
The case may require endocrine oncology, surgery, medical oncology and endocrinology input.
Most delays happen when the diagnosis is described verbally but the file lacks dates, reports, imaging, pathology or the current specialist recommendation. The documents below are requested before the file is considered ready for review.
The page does not present a hospital visit or travel plan as automatically suitable. Any Cuba-related discussion remains conditional on physician review of the current file.
Uncontrolled hormonal syndromes need local stabilization.
The file is organized to avoid unsafe assumptions about diagnosis or treatment.
The case may require more than one specialist opinion before coordination proceeds.
International coordination should never delay emergency care. If any of the following are present, the patient should be assessed locally first.
No. It explains how the file is organized for review. Suitability, route, timing and safety can only be determined by physicians after reviewing the complete current record.
A summary helps, but it is not enough for most oncology reviews. Pathology, imaging, treatment history, lab results and the latest oncology note are usually needed.
No. Cuba Health Assist coordinates records, communication, translation support and logistics. Medical decisions remain with licensed physicians and the patient’s treating team.
The team will request missing reports before presenting the case as ready. This protects the patient from receiving a weak or unrealistic response.
No. Severe or rapidly worsening symptoms require local emergency or oncology care first. International coordination is not an emergency service.
A coordinator will organize the medical information and guide the next step according to specialist review. The process is designed to be transparent, clinically cautious and written.